1. After 24 years i have achieved a sort of landmark- i have published my 1000th peer reviewed publication ➡️ https://t.co/JqW6CB9pjf My first paper was around spinal cord injury, and for the 1000th paper It is fitting that it was: Percutaneous Coronary Intervention in the UK:

Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Tria Both dual and triple LLT after ACS allow for high rates (>50%) of adequate LDL-C control (<55 mg/dL) at 8 weeks. Adding bempedoic acid to statin–ezetimibe therapy in

PAs in cardiology are encroaching on procedures and ward duties, with 29% performing cardiology procedures and 12.6% acting beyond their scope, leaving early-stage trainees overworked and undertrained. This threatens the future of cardiology specialists and patient safety.

Excluding the indications for non-surgical procedures such as #TEER, this article examines the context and current status of isolated #MV_surgery in #FMR. A potential decision-making algorithm for surgical #MV interventions, based on the current accumulated evidence is presented.

1/ Do you perform invasive coronary physiology? Do you do it correctly (we all assume that we do)? Lets do a deep dive into current practices. @SVRaoMD @realarainmd @Ajar_Kochar @mirvatalasnag @MichaelMegalyMD @mmamas1973 @DrDamluji @AntoniousAttall

Happy belated birthday @biljana_parapid my wonderful friend- i hope you have many more years enjoying ice cream 🤣😜

We published an Educational interactive Case- mainly for medical students and residents on #AF Atrial Fibrillation https://t.co/opY0K1axE6 It is really educational and worth a read! @DrMarthaGulati @Hragy @mmamas1973 @purviparwani @AnastasiaSMihai @EkateriniL @gbiondizoccai

In Stent #CTO #LAD Should the hybrid algorithm be changed to #HDRfirst in stent CTO? #maytheforcebewithyou @realarainmd @Laserrman @MauroCarlino3 @mmamas1973 @mirvatalasnag @jedicath @tadano98 @KVM83 @KovacicMihajlo @MichaelMegalyMD @MPAOSS @OjedaOjeda18 @foroepic @RumoJose

#CVimagers #Cardiologist #CardiologyFellows #CardiologyPD Have you checked out the *NEW* Advanced Training Statement on Advanced #CVimaging by @ACCinTouch /@AHAScience and #CVImaging societies? The 2025 ACC/AHA multimodality imaging statement defines a new kind of cardiovascular

@hvanspall @DrMarthaGulati @Hragy @iamritu @vass_vassiliou @DocSavageTJU @TheWarholMuseum

And finally Andy Warhols piss painting , which are the Oxidation Paintings series, created by coating canvases in a metallic copper-based paint and then urinating on them. 😳😳😳 the end. I hope you enjoyed tour

From his death and disaster series- white disaster, opticalcar crash and electric chair

The famous single elvis, and more photographs from Warhol. Some popart- skulls from 1976

Some more classical warhol- a silver cleoptra (Elizabeth Taylor), Jackie Kennedy and Flowers

The first 2 pictures are pollock- the last 2 are warhol. Pollock would put canvas on floor and run over the canvas with a bike, would use syringes and paint cans with holes in to paint

Incredible visit to the national museum thyssen in Madrid to visit the warhol pollock exhibition at #RENEW_PCI - the silver in last painting was car paint!

Delighted to discuss the #Vesalius CV trial with Dr Erin Bohula #AHA25 @radcliffeCARDIO In 12.3K patients at high #risk for #CV events but no prior MI or stroke, #evolocumab sc: ⬇️ 3 point #MACE by 25% (2.2%ARR @ 5y) ⬇️ 4 point MACE by 19% Associated with ⬇️☠️

Sacubitril-Valsartan for the Prevention of Anthracycline Cardiotoxicity in Patients With Elevated Cardiac Troponin I Concentration During Chemotherapy: A Double-Blind Randomized Placebo-Controlled Clinical Trial: The SARAH Trial The SARAH trial (Sacubitril-Valsartan for the

Godzilla 😳 i don't know what that says about me 🤣

Delighted to share our paper published ahead of print @Hypertens_Res for the sex-stratified analysis that I initiated to 🔎women with resistant #hypertension from the Global SYMPLICITY Registry of #RDN https://t.co/AGwl2v1SIT @NthSydHealth @KollingINST @Ravinay @OzCvA